Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
A clinical trial update announcing collection of blood from healthy individuals, patients with benign disease, and cancer patients sponsored…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Registry update for the National Australian Hepatitis C point-of-care testing program showing recruitment ongoing.
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
An ongoing clinical study in Colombia evaluating adult screening for hepatitis C and linking patients to treatment in hospital settings; cur…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Hepatitis C Pharmacy-based Strategy for Injectors
A completed clinical trial (NCT04698629) evaluating a pharmacy-based strategy for delivering Hepatitis C treatment. Results were posted on 2…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Maraviroc Efficacy for Hepatitis C [Phase 4]
Phase 4 clinical trial update assessing maraviroc for hepatitis C in HIV-infected individuals; the study has completed and results were post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: HCV Seek, Test and Rapid Treatment for Young PWID [NA]
Completed clinical trial from Weill Medical College of Cornell University evaluating rapid Hepatitis C testing and treatment among young peo…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM [NA]
Clinical trial update indicating recruitment for a study of serious game interventions to reduce Hepatitis C among people living with HIV wh…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil) [Phase 4]
Phase 4 trial updating safety and efficacy of decentralized Hepatitis C treatment versus standard-of-care in Rio de Janeiro.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir [Phase 4]
A Phase 4 clinical trial update investigating a reduced treatment strategy using a SOF/Glecepravir-pibrentasvir regimen for very early liver…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults [NA]
A completed clinical trial evaluating a community-based intervention to improve treatment completion among adults with Hepatitis C virus inf…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: UHN Inpatient Hepatitis C & B Screening [Phase 4]
A Phase 4 clinical trial update regarding inpatient screening for Hepatitis C and Hepatitis B at UHN.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy [Phase 4]
Phase 4 trial update on pegylated interferon and ribavirin in hepatitis C patients receiving opioid pharmacotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors [Phase 4]
Phase 4 trial evaluating kidney transplants from hepatitis C viremic donors into hepatitis C negative recipients (in end-stage renal disease…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) [NA]
A completed clinical trial update from CARE2HOPE initiative addressing substance use and HIV-related conditions, with results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30% [Phase 4]
A Phase 4 clinical trial update on preparing for the final phase of Hepatitis C elimination.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Same-visit Hepatitis C Testing and Treatment (The QuickStart Study) [Phase 4]
A Phase 4 clinical trial update assessing same-visit testing and treatment for Hepatitis C (The QuickStart Study).
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) [Phase 4]
Phase 4 clinical trial update on drug use and infections in Vietnam focusing on Hepatitis C.
-
FDA approval · 2023-10-25FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
FDA document regarding a supplemental application for MAVYRET (glecaprevir and pibrentasvir) by AbbVie.
-
FDA approval · 2023-10-25FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) from AbbVie.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy. [Phase 3]
Phase 3 trial evaluating whether zinc sulfate has an antifibrotic effect in chronic hepatitis C patients receiving direct-acting antiviral t…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
A clinical trial registry entry for cirrhosis patients achieving sustained virologic response with a sofosbuvir-based, interferon-free regim…
-
EMA approval · 2023-09-27EMA Authorised: Epclusa (sofosbuvir;velpatasvir) — Gilead Sciences Ireland UC
EPAR entry indicating EMA authorised Epclusa (sofosbuvir/velpatasvir) for chronic hepatitis C, with Gilead as MAH and accelerated assessment…
-
EMA approval · 2023-09-27EMA Authorised: Vosevi (sofosbuvir;velpatasvir;voxilaprevi) — Gilead Sciences Ireland UC
EMA authorised Vosevi (sofosbuvir; velpatasvir; voxilaprevir) for chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Utilization of Hepatitis C Positive Kidneys in Negative Recipients [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the use of hepatitis C positive donor kidneys transplanted into hepatitis C negative recipients; study c…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection [Phase 4]
Phase 4 trial update assessing safety and efficacy of Sofosbuvir-based regimens in Egyptian patients with hepatitis C.